세계의 요관 스텐트 시장 규모, 점유율 및 산업 동향 분석 보고서 : 최종 사용자, 재료, 제품, 용도 및 지역별 전망 및 예측(2023-2030년)

The Global Ureteral Stents Market size is expected to reach $883.2 million by 2030, rising at a market growth of 6.5% CAGR during the forecast period. In the year 2022, the market attained a volume of 11,924.9 thousand units experiencing a growth of 6.2% (2019-2022).

Silicone stents are known for their biocompatibility, flexibility, and durability within the body. Their ability to minimize irritation and inflammation in the urinary tract can contribute to increased demand, especially in cases where long-term stenting is necessary. Consequently, the Silicone stents segment would acquire nearly 40% of the total Polymer Stent market share by 2030. Ongoing improvements in silicone stent design, including modifications to reduce migration, enhance drainage, and minimize tissue trauma, drive demand as these devices become more effective and reliable. Some of the factors impacting the market are rising incidences of urological disorders, shift towards minimally invasive procedures in urology and side effects and discomfort associated with the stents.

Kidney stones are a common urological condition, and their incidence has risen globally. Factors such as dietary habits, dehydration, and genetics contribute to the formation of kidney stones. These stents are frequently utilized in managing kidney stones, facilitating the passage of stone fragments, and alleviating symptoms. The incidence of urological tumors, such as bladder or renal cancers, has been on the rise. These stents may be used as part of the treatment strategy for managing obstructions caused by tumors or for post-surgical support. These factors will pose lucrative growth prospects for the market. Additionally, minimally invasive procedures, including the placement of these stents, generally result in quicker recovery times for patients. Compared to traditional open surgeries, which may involve larger incisions and longer recovery periods, minimally invasive techniques are associated with reduced trauma to tissues, allowing patients to recover more swiftly. Smaller incisions and reduced tissue trauma result in a lower level of discomfort for patients undergoing procedures such as ureteral stent placement. These aspects will help in the expansion of the market.

However, the stents can cause an increased sensation of urgency, prompting patients to feel the need to urinate more frequently. This can be bothersome and affect daily activities, potentially leading to disruptions in normal routines. In addition, hematuria, or blood in the urine, is a common side effect of these stents. This can occur due to the stent's irritation of the urinary tract tissues. While it is often not a cause for major concern, it can be alarming for patients and may lead to anxiety. These factors are expected to hamper the growth of the market.

Moreover, one of the significant impacts of the pandemic has been the postponement of elective and non-urgent medical procedures to prioritize resources for COVID-19 patients. Ureteral stent placements, which may be considered elective in certain cases, faced delays as hospitals and healthcare facilities redirected their focus toward managing the pandemic. Additionally, the global supply chain disruptions caused by the pandemic affected the availability of medical devices, including these stents. Manufacturers faced challenges related to production, distribution, and the sourcing of raw materials, which impacted the supply and demand dynamics of the market. Therefore, the COVID-19 pandemic adversely affected the market.

End User Outlook

Based on end user, the market is divided into hospitals and ambulatory surgical centers (ASCS) & clinics. In 2022, the ambulatory surgical centers (ASCS) & clinics segment witnessed a substantial revenue share in the market. ASCs and clinics are well-suited for performing minimally invasive procedures, such as placing stents. ASCs and clinics often provide cost-effective alternatives for surgical and medical procedures compared to traditional hospital settings. The lower overhead costs of these facilities contribute to a more affordable healthcare option for patients, payers, and providers. Thus, these factors will pose lucrative growth prospects for the segment.

Material Outlook

Based on material, the market is segmented into metallic stents and polymer stents. In 2022, the polymer stents segment garnered a significant revenue share in the market. Polymer stents are designed to be biocompatible, meaning they are well-tolerated by the body's tissues. This characteristic reduces the risk of tissue irritation, inflammation, and adverse reactions compared to stents made from materials that may be less compatible with the biological environment. Owing to these benefits, the segment will grow rapidly in the coming years.

Product Outlook

On the basis of product, the market is divided into double pigtail stent, open/closed pigtail stent, and multiloop stents. In 2022, the open/closed pigtail stent segment witnessed a substantial revenue share in the market. These are specific designs of these stents characterized by a coiled or pigtail structure at one or both ends. The design helps anchor the stent within the urinary tract and prevent migration. The choice between open and closed pigtail stents may depend on factors such as the nature of the urological condition, the patient's anatomy, and the surgeon's preference. The effectiveness of these stents in managing specific cases could influence their adoption. Therefore, these aspects will help in the expansion of the segment.

Application Outlook

On the basis of application, the market is divided into kidney transplantation, kidney stones, tumors, urinary incontinence, and others. The kidney transplantation segment held a significant revenue share in the market in 2022. These stents play a crucial role in supporting the postoperative period and ensuring the success of the transplantation. After kidney transplantation, the donor kidney's ureter needs to be connected to the recipient's bladder. The stents are often placed during this surgical procedure to facilitate healing and to ensure proper alignment of the ureter with the bladder. These aspects will boost the demand in the segment.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America has a relatively high incidence of kidney stones and related urological issues, contributing to the demand for these stents. Continuous advancements in medical technology and the development of innovative stents contribute to market growth. North America, with its strong focus on healthcare research and development, often sees the introduction of new and advanced medical devices, including these stents. Therefore, these aspects will pose lucrative growth prospects for the North America segment.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company

Scope of the Study

Market Segments covered in the Report:

By End User (Volume, Thousand Units, Revenue, USD Million, 2019-30)

• Hospitals
• Ambulatory Surgical Centers (ASCS) & Clinics

By Material (Volume, Thousand Units, Revenue, USD Million, 2019-30)

• Metallic Stents
• Polymer Stents
  • Silicone Ureteral Stents
  • Hybrid Ureteral Stents
  • Polyurethane Stents

By Product (Volume, Thousand Units, Revenue, USD Million, 2019-30)

• Double Pigtail Stent
• Open/Closed Pigtail Stent
• Multiloop Stents

By Application (Volume, Thousand Units, Revenue, USD Million, 2019-30)

• Kidney Stones
• Kidney Transplantation
• Urinary Incontinence
• Tumors
• Others

By Geography (Volume, Thousand Units, Revenue, USD Million, 2019-30)

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Boston Scientific Corporation
• B. Braun Melsungen AG
• Coloplast Group
• Medline Industries, Inc.
• Allium Ltd
• Cook Medical, Inc. (Cook Group)
• Pnn Medical A/S
• Teleflex, Inc.
• Olympus Corporation
• Becton, Dickinson, and Company

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Ureteral Stents Market, by End User
  • 1.4.2 Global Ureteral Stents Market, by Material
  • 1.4.3 Global Ureteral Stents Market, by Product
  • 1.4.4 Global Ureteral Stents Market, by Application
  • 1.4.5 Global Ureteral Stents Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market At a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter's Five Forces Analysis

Chapter 4. Global Ureteral Stents Market by End User

• 4.1 Global Hospitals Market by Region
• 4.2 Global Ambulatory Surgical Centers (ASCS) & Clinics Market by Region

Chapter 5. Global Ureteral Stents Market by Material

• 5.1 Global Metallic Stents Market by Region
• 5.2 Global Polymer Stents Market by Region
• 5.3 Global Ureteral Stents Market by Polymer Stents Type
  • 5.3.1 Global Silicone Ureteral Stents Market by Region
  • 5.3.2 Global Hybrid Ureteral Stents Market by Region
  • 5.3.3 Global Polyurethane Stents Market by Region

Chapter 6. Global Ureteral Stents Market by Product

• 6.1 Global Double Pigtail Stent Market by Region
• 6.2 Global Open/Closed Pigtail Stent Market by Region
• 6.3 Global Multiloop Stents Market by Region

Chapter 7. Global Ureteral Stents Market by Application

• 7.1 Global Kidney Stones Market by Region
• 7.2 Global Kidney Transplantation Market by Region
• 7.3 Global Urinary Incontinence Market by Region
• 7.4 Global Tumors Market by Region
• 7.5 Global Others Market by Region

Chapter 8. Global Ureteral Stents Market by Region

• 8.1 North America Ureteral Stents Market
  • 8.1.1 North America Ureteral Stents Market by End User
    • 8.1.1.1 North America Hospitals Market by Region
    • 8.1.1.2 North America Ambulatory Surgical Centers (ASCS) & Clinics Market by Region
  • 8.1.2 North America Ureteral Stents Market by Material
    • 8.1.2.1 North America Metallic Stents Market by Region
    • 8.1.2.2 North America Polymer Stents Market by Region
    • 8.1.2.3 North America Ureteral Stents Market by Polymer Stents Type
      • 8.1.2.3.1 North America Silicone Ureteral Stents Market by Country
      • 8.1.2.3.2 North America Hybrid Ureteral Stents Market by Country
      • 8.1.2.3.3 North America Polyurethane Stents Market by Country
  • 8.1.3 North America Ureteral Stents Market by Product
    • 8.1.3.1 North America Double Pigtail Stent Market by Country
    • 8.1.3.2 North America Open/Closed Pigtail Stent Market by Country
    • 8.1.3.3 North America Multiloop Stents Market by Country
  • 8.1.4 North America Ureteral Stents Market by Application
    • 8.1.4.1 North America Kidney Stones Market by Country
    • 8.1.4.2 North America Kidney Transplantation Market by Country
    • 8.1.4.3 North America Urinary Incontinence Market by Country
    • 8.1.4.4 North America Tumors Market by Country
    • 8.1.4.5 North America Others Market by Country
  • 8.1.5 North America Ureteral Stents Market by Country
    • 8.1.5.1 US Ureteral Stents Market
      • 8.1.5.1.1 US Ureteral Stents Market by End User
      • 8.1.5.1.2 US Ureteral Stents Market by Material
      • 8.1.5.1.3 US Ureteral Stents Market by Product
      • 8.1.5.1.4 US Ureteral Stents Market by Application
    • 8.1.5.2 Canada Ureteral Stents Market
      • 8.1.5.2.1 Canada Ureteral Stents Market by End User
      • 8.1.5.2.2 Canada Ureteral Stents Market by Material
      • 8.1.5.2.3 Canada Ureteral Stents Market by Product
      • 8.1.5.2.4 Canada Ureteral Stents Market by Application
    • 8.1.5.3 Mexico Ureteral Stents Market
      • 8.1.5.3.1 Mexico Ureteral Stents Market by End User
      • 8.1.5.3.2 Mexico Ureteral Stents Market by Material
      • 8.1.5.3.3 Mexico Ureteral Stents Market by Product
      • 8.1.5.3.4 Mexico Ureteral Stents Market by Application
    • 8.1.5.4 Rest of North America Ureteral Stents Market
      • 8.1.5.4.1 Rest of North America Ureteral Stents Market by End User
      • 8.1.5.4.2 Rest of North America Ureteral Stents Market by Material
      • 8.1.5.4.3 Rest of North America Ureteral Stents Market by Product
      • 8.1.5.4.4 Rest of North America Ureteral Stents Market by Application
• 8.2 Europe Ureteral Stents Market
  • 8.2.1 Europe Ureteral Stents Market by End User
    • 8.2.1.1 Europe Hospitals Market by Country
    • 8.2.1.2 Europe Ambulatory Surgical Centers (ASCS) & Clinics Market by Country
  • 8.2.2 Europe Ureteral Stents Market by Material
    • 8.2.2.1 Europe Metallic Stents Market by Country
    • 8.2.2.2 Europe Polymer Stents Market by Country
    • 8.2.2.3 Europe Ureteral Stents Market by Polymer Stents Type
      • 8.2.2.3.1 Europe Silicone Ureteral Stents Market by Country
      • 8.2.2.3.2 Europe Hybrid Ureteral Stents Market by Country
      • 8.2.2.3.3 Europe Polyurethane Stents Market by Country
  • 8.2.3 Europe Ureteral Stents Market by Product
    • 8.2.3.1 Europe Double Pigtail Stent Market by Country
    • 8.2.3.2 Europe Open/Closed Pigtail Stent Market by Country
    • 8.2.3.3 Europe Multiloop Stents Market by Country
  • 8.2.4 Europe Ureteral Stents Market by Application
    • 8.2.4.1 Europe Kidney Stones Market by Country
    • 8.2.4.2 Europe Kidney Transplantation Market by Country
    • 8.2.4.3 Europe Urinary Incontinence Market by Country
    • 8.2.4.4 Europe Tumors Market by Country
    • 8.2.4.5 Europe Others Market by Country
  • 8.2.5 Europe Ureteral Stents Market by Country
    • 8.2.5.1 Germany Ureteral Stents Market
      • 8.2.5.1.1 Germany Ureteral Stents Market by End User
      • 8.2.5.1.2 Germany Ureteral Stents Market by Material
      • 8.2.5.1.3 Germany Ureteral Stents Market by Product
      • 8.2.5.1.4 Germany Ureteral Stents Market by Application
    • 8.2.5.2 UK Ureteral Stents Market
      • 8.2.5.2.1 UK Ureteral Stents Market by End User
      • 8.2.5.2.2 UK Ureteral Stents Market by Material
      • 8.2.5.2.3 UK Ureteral Stents Market by Product
      • 8.2.5.2.4 UK Ureteral Stents Market by Application
    • 8.2.5.3 France Ureteral Stents Market
      • 8.2.5.3.1 France Ureteral Stents Market by End User
      • 8.2.5.3.2 France Ureteral Stents Market by Material
      • 8.2.5.3.3 France Ureteral Stents Market by Product
      • 8.2.5.3.4 France Ureteral Stents Market by Application
    • 8.2.5.4 Russia Ureteral Stents Market
      • 8.2.5.4.1 Russia Ureteral Stents Market by End User
      • 8.2.5.4.2 Russia Ureteral Stents Market by Material
      • 8.2.5.4.3 Russia Ureteral Stents Market by Product
      • 8.2.5.4.4 Russia Ureteral Stents Market by Application
    • 8.2.5.5 Spain Ureteral Stents Market
      • 8.2.5.5.1 Spain Ureteral Stents Market by End User
      • 8.2.5.5.2 Spain Ureteral Stents Market by Material
      • 8.2.5.5.3 Spain Ureteral Stents Market by Product
      • 8.2.5.5.4 Spain Ureteral Stents Market by Application
    • 8.2.5.6 Italy Ureteral Stents Market
      • 8.2.5.6.1 Italy Ureteral Stents Market by End User
      • 8.2.5.6.2 Italy Ureteral Stents Market by Material
      • 8.2.5.6.3 Italy Ureteral Stents Market by Product
      • 8.2.5.6.4 Italy Ureteral Stents Market by Application
    • 8.2.5.7 Rest of Europe Ureteral Stents Market
      • 8.2.5.7.1 Rest of Europe Ureteral Stents Market by End User
      • 8.2.5.7.2 Rest of Europe Ureteral Stents Market by Material
      • 8.2.5.7.3 Rest of Europe Ureteral Stents Market by Product
      • 8.2.5.7.4 Rest of Europe Ureteral Stents Market by Application
• 8.3 Asia Pacific Ureteral Stents Market
  • 8.3.1 Asia Pacific Ureteral Stents Market by End User
    • 8.3.1.1 Asia Pacific Hospitals Market by Country
    • 8.3.1.2 Asia Pacific Ambulatory Surgical Centers (ASCS) & Clinics Market by Country
  • 8.3.2 Asia Pacific Ureteral Stents Market by Material
    • 8.3.2.1 Asia Pacific Metallic Stents Market by Country
    • 8.3.2.2 Asia Pacific Polymer Stents Market by Country
    • 8.3.2.3 Asia Pacific Ureteral Stents Market by Polymer Stents Type
      • 8.3.2.3.1 Asia Pacific Silicone Ureteral Stents Market by Country
      • 8.3.2.3.2 Asia Pacific Hybrid Ureteral Stents Market by Country
      • 8.3.2.3.3 Asia Pacific Polyurethane Stents Market by Country
  • 8.3.3 Asia Pacific Ureteral Stents Market by Product
    • 8.3.3.1 Asia Pacific Double Pigtail Stent Market by Country
    • 8.3.3.2 Asia Pacific Open/Closed Pigtail Stent Market by Country
    • 8.3.3.3 Asia Pacific Multiloop Stents Market by Country
  • 8.3.4 Asia Pacific Ureteral Stents Market by Application
    • 8.3.4.1 Asia Pacific Kidney Stones Market by Country
    • 8.3.4.2 Asia Pacific Kidney Transplantation Market by Country
    • 8.3.4.3 Asia Pacific Urinary Incontinence Market by Country
    • 8.3.4.4 Asia Pacific Tumors Market by Country
    • 8.3.4.5 Asia Pacific Others Market by Country
  • 8.3.5 Asia Pacific Ureteral Stents Market by Country
    • 8.3.5.1 China Ureteral Stents Market
      • 8.3.5.1.1 China Ureteral Stents Market by End User
      • 8.3.5.1.2 China Ureteral Stents Market by Material
      • 8.3.5.1.3 China Ureteral Stents Market by Product
      • 8.3.5.1.4 China Ureteral Stents Market by Application
    • 8.3.5.2 Japan Ureteral Stents Market
      • 8.3.5.2.1 Japan Ureteral Stents Market by End User
      • 8.3.5.2.2 Japan Ureteral Stents Market by Material
      • 8.3.5.2.3 Japan Ureteral Stents Market by Product
      • 8.3.5.2.4 Japan Ureteral Stents Market by Application
    • 8.3.5.3 India Ureteral Stents Market
      • 8.3.5.3.1 India Ureteral Stents Market by End User
      • 8.3.5.3.2 India Ureteral Stents Market by Material
      • 8.3.5.3.3 India Ureteral Stents Market by Product
      • 8.3.5.3.4 India Ureteral Stents Market by Application
    • 8.3.5.4 South Korea Ureteral Stents Market
      • 8.3.5.4.1 South Korea Ureteral Stents Market by End User
      • 8.3.5.4.2 South Korea Ureteral Stents Market by Material
      • 8.3.5.4.3 South Korea Ureteral Stents Market by Product
      • 8.3.5.4.4 South Korea Ureteral Stents Market by Application
    • 8.3.5.5 Singapore Ureteral Stents Market
      • 8.3.5.5.1 Singapore Ureteral Stents Market by End User
      • 8.3.5.5.2 Singapore Ureteral Stents Market by Material
      • 8.3.5.5.3 Singapore Ureteral Stents Market by Product
      • 8.3.5.5.4 Singapore Ureteral Stents Market by Application
    • 8.3.5.6 Malaysia Ureteral Stents Market
      • 8.3.5.6.1 Malaysia Ureteral Stents Market by End User
      • 8.3.5.6.2 Malaysia Ureteral Stents Market by Material
      • 8.3.5.6.3 Malaysia Ureteral Stents Market by Product
      • 8.3.5.6.4 Malaysia Ureteral Stents Market by Application
    • 8.3.5.7 Rest of Asia Pacific Ureteral Stents Market
      • 8.3.5.7.1 Rest of Asia Pacific Ureteral Stents Market by End User
      • 8.3.5.7.2 Rest of Asia Pacific Ureteral Stents Market by Material
      • 8.3.5.7.3 Rest of Asia Pacific Ureteral Stents Market by Product
      • 8.3.5.7.4 Rest of Asia Pacific Ureteral Stents Market by Application
• 8.4 LAMEA Ureteral Stents Market
  • 8.4.1 LAMEA Ureteral Stents Market by End User
    • 8.4.1.1 LAMEA Hospitals Market by Country
    • 8.4.1.2 LAMEA Ambulatory Surgical Centers (ASCS) & Clinics Market by Country
  • 8.4.2 LAMEA Ureteral Stents Market by Material
    • 8.4.2.1 LAMEA Metallic Stents Market by Country
    • 8.4.2.2 LAMEA Polymer Stents Market by Country
    • 8.4.2.3 LAMEA Ureteral Stents Market by Polymer Stents Type
      • 8.4.2.3.1 LAMEA Silicone Ureteral Stents Market by Country
      • 8.4.2.3.2 LAMEA Hybrid Ureteral Stents Market by Country
      • 8.4.2.3.3 LAMEA Polyurethane Stents Market by Country
  • 8.4.3 LAMEA Ureteral Stents Market by Product
    • 8.4.3.1 LAMEA Double Pigtail Stent Market by Country
    • 8.4.3.2 LAMEA Open/Closed Pigtail Stent Market by Country
    • 8.4.3.3 LAMEA Multiloop Stents Market by Country
  • 8.4.4 LAMEA Ureteral Stents Market by Application
    • 8.4.4.1 LAMEA Kidney Stones Market by Country
    • 8.4.4.2 LAMEA Kidney Transplantation Market by Country
    • 8.4.4.3 LAMEA Urinary Incontinence Market by Country
    • 8.4.4.4 LAMEA Tumors Market by Country
    • 8.4.4.5 LAMEA Others Market by Country
  • 8.4.5 LAMEA Ureteral Stents Market by Country
    • 8.4.5.1 Brazil Ureteral Stents Market
      • 8.4.5.1.1 Brazil Ureteral Stents Market by End User
      • 8.4.5.1.2 Brazil Ureteral Stents Market by Material
      • 8.4.5.1.3 Brazil Ureteral Stents Market by Product
      • 8.4.5.1.4 Brazil Ureteral Stents Market by Application
    • 8.4.5.2 Argentina Ureteral Stents Market
      • 8.4.5.2.1 Argentina Ureteral Stents Market by End User
      • 8.4.5.2.2 Argentina Ureteral Stents Market by Material
      • 8.4.5.2.3 Argentina Ureteral Stents Market by Product
      • 8.4.5.2.4 Argentina Ureteral Stents Market by Application
    • 8.4.5.3 UAE Ureteral Stents Market
      • 8.4.5.3.1 UAE Ureteral Stents Market by End User
      • 8.4.5.3.2 UAE Ureteral Stents Market by Material
      • 8.4.5.3.3 UAE Ureteral Stents Market by Product
      • 8.4.5.3.4 UAE Ureteral Stents Market by Application
    • 8.4.5.4 Saudi Arabia Ureteral Stents Market
      • 8.4.5.4.1 Saudi Arabia Ureteral Stents Market by End User
      • 8.4.5.4.2 Saudi Arabia Ureteral Stents Market by Material
      • 8.4.5.4.3 Saudi Arabia Ureteral Stents Market by Product
      • 8.4.5.4.4 Saudi Arabia Ureteral Stents Market by Application
    • 8.4.5.5 South Africa Ureteral Stents Market
      • 8.4.5.5.1 South Africa Ureteral Stents Market by End User
      • 8.4.5.5.2 South Africa Ureteral Stents Market by Material
      • 8.4.5.5.3 South Africa Ureteral Stents Market by Product
      • 8.4.5.5.4 South Africa Ureteral Stents Market by Application
    • 8.4.5.6 Nigeria Ureteral Stents Market
      • 8.4.5.6.1 Nigeria Ureteral Stents Market by End User
      • 8.4.5.6.2 Nigeria Ureteral Stents Market by Material
      • 8.4.5.6.3 Nigeria Ureteral Stents Market by Product
      • 8.4.5.6.4 Nigeria Ureteral Stents Market by Application
    • 8.4.5.7 Rest of LAMEA Ureteral Stents Market
      • 8.4.5.7.1 Rest of LAMEA Ureteral Stents Market by End User
      • 8.4.5.7.2 Rest of LAMEA Ureteral Stents Market by Material
      • 8.4.5.7.3 Rest of LAMEA Ureteral Stents Market by Product
      • 8.4.5.7.4 Rest of LAMEA Ureteral Stents Market by Application

Chapter 9. Company Profiles

• 9.1 Boston Scientific Corporation
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Segmental and Regional Analysis
  • 9.1.4 Research & Development Expense
  • 9.1.5 SWOT Analysis
• 9.2 B. Braun Melsungen AG
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Segmental and Regional Analysis
  • 9.2.4 Research & Development Expenses
  • 9.2.5 SWOT Analysis
• 9.3 Coloplast Group
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expense
  • 9.3.5 SWOT Analysis
• 9.4 Medline Industries, Inc.
  • 9.4.1 Company Overview
  • 9.4.2 SWOT Analysis
• 9.5 Allium Ltd
  • 9.5.1 Company Overview
  • 9.5.2 SWOT Analysis
• 9.6 Cook Medical, Inc. (Cook Group)
  • 9.6.1 Company Overview
  • 9.6.2 SWOT Analysis
• 9.7 Pnn Medical A/S
  • 9.7.1 Company Overview
  • 9.7.2 SWOT Analysis
• 9.8 Teleflex, Inc.
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Segmental Analysis
  • 9.8.4 Research & Development Expense
  • 9.8.5 SWOT Analysis
• 9.9 Olympus Corporation
  • 9.9.1 Company Overview
  • 9.9.2 Financial Analysis
  • 9.9.3 Segmental and Regional Analysis
  • 9.9.4 Recent strategies and developments:
    • 9.9.4.1 Product Launches and Product Expansions:
    • 9.9.4.2 Acquisition and Mergers:
  • 9.9.5 SWOT Analysis
• 9.10. Becton, Dickinson, and Company
  • 9.10.1 Company Overview
  • 9.10.2 Financial Analysis
  • 9.10.3 Segmental and Regional Analysis
  • 9.10.4 Research & Development Expense
  • 9.10.5 SWOT Analysis

Chapter 10. Winning Imperatives of Ureteral Stents Market